Literature DB >> 10435044

Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass.

S Zahler1, P Massoudy, H Hartl, C Hähnel, H Meisner, B F Becker.   

Abstract

OBJECTIVES: The investigation centers on whether there is a reperfusion-induced specific cardiac inflammatory reaction after bypass surgery.
BACKGROUND: Cardiopulmonary bypass (CPB) leads to systemic inflammation. Additionally, cardiac inflammation due to reperfusion could occur. Knowledge about nature and time course of this reaction might help to develop cardioprotective interventions.
METHODS: In 12 patients receiving coronary bypass grafts, arterial and coronary venous blood was obtained before onset of CPB, and 1, 5, 10, 25, 35 and 75 min after cardiac reperfusion. Plasma levels of IL6 and IL8 were measured by immunoassay. CD11b, CD41, and CD62 on blood cells were quantified by flow cytometry. Measurement of CD41, a platelet marker, on neutrophils and monocytes allowed detection of leukocyte-platelet microaggregates.
RESULTS: Transcardiac veno-arterial difference of IL6 rose in the 10th and 25th min of reperfusion (from 0 to 7 pg/ml; p < 0.05), and after 75 min (15 pg/ml). IL8 did not change. CD11b on neutrophils (PMN) decreased transcardially to 95, 88 and 82% of the initial level in the 5th, 10th, and 75th min, respectively, suggesting sequestration of activated neutrophils. CD62 on platelets rose about 30% in the 75th min. Initially, leukocyte-platelet microaggregates were formed during coronary passage (+31% of the arterial level for PMN, +23% for monocytes). During reperfusion, coaggregates were retained (PMN: -1% and -7% in the 5th and 10th min, monocytes: -22%, -13% and -12% in the 1st, 5th and 10th min.
CONCLUSIONS: During early reperfusion after aortic declamping, the coronary bed is already a source of proinflammatory stimuli and target for activated leukocytes, partly in conjunction with platelets. Mitigation of these phenomena might help to improve cardiac function after CPB especially in patients at risk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435044     DOI: 10.1016/s0008-6363(98)00229-6

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  34 in total

1.  Transcatheter closure of atrial septal defects improves right ventricular volume, mass, function, pulmonary pressure, and functional class: a magnetic resonance imaging study.

Authors:  S P Schoen; T Kittner; S Bohl; M U Braun; G Simonis; A Schmeisser; R H Strasser
Journal:  Heart       Date:  2005-11-11       Impact factor: 5.994

Review 2.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

3.  Examining the Use of Sodium Nitroprusside in Coronary Artery Bypass Grafting: Is the Benefit Worth the Cost?

Authors:  Caitlin M Gibson; Sondra Davis; Darien Bradford
Journal:  Hosp Pharm       Date:  2017-07-30

4.  Myocardial Inactivation of Thyroid Hormones in Patients with Aortic Stenosis.

Authors:  Bruno S Paolino; Pablo M Pomerantzeff; Luís Alberto O Dallan; Fabio A Gaiotto; Nailliw Z Preite; Ana Claudia Latrônico; José Carlos Nicolau; Antonio C Bianco; Roberto R C V Giraldez
Journal:  Thyroid       Date:  2017-04-12       Impact factor: 6.568

Review 5.  Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications.

Authors:  Jun Li; Hanrui Zhang; Cuihua Zhang
Journal:  J Mol Cell Cardiol       Date:  2011-09-05       Impact factor: 5.000

6.  Transcatheter closure of atrial septal defect preserves right ventricular function.

Authors:  R Dhillon; M Josen; M Henein; A Redington
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

7.  The acute cardioprotective effect of glucocorticoid in myocardial ischemia-reperfusion injury occurring during cardiopulmonary bypass.

Authors:  Yavuz Enc; Pelin Karaca; Umut Ayoglu; Gercek Camur; Erol Kurc; Sertac Cicek
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

8.  Protective effect of silymarin during coronary artery bypass grafting surgery.

Authors:  Tagreed Altaei
Journal:  Exp Clin Cardiol       Date:  2012

9.  Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI.

Authors:  Zequan Yang; Joel Linden; Stuart S Berr; Irving L Kron; George A Beller; Brent A French
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

10.  Gadolinium decreases inflammation related to myocardial ischemia and reperfusion injury.

Authors:  Jennifer L Strande; Kasi V Routhu; Anna Hsu; Alfred C Nicolosi; John E Baker
Journal:  J Inflamm (Lond)       Date:  2009-12-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.